Pharmaceuticals

Imlygic Market 2026 expanding with oncolytic virus therapies

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Imlygic Market By The End Of 2030?

The historical expansion was driven by a scarcity of treatment choices for unresectable melanoma, significant early advancements in immunotherapy, an increase in melanoma cases, the clinical endorsement of viral oncology, and the integration by oncology centers.

The projected growth throughout the forecast period stems from the expansion of cancer immunotherapy pipelines, an increase in combination oncology trials, heightened investment in viral therapeutics, rising rates of melanoma diagnosis, and advancements in genetic modification technologies. Simultaneously, significant trends expected during this period include the progression of oncolytic viral therapies, a surging interest in immuno-oncology, the broadening of injectable cancer therapies, a concentrated effort on localized tumor treatment, and an increase in combination therapy approaches.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20097&type=smp

What Primary Drivers Are Shaping The Development Of The Imlygic Market?

The Imlygic market is projected to expand due to the increasing occurrence of melanoma. Melanoma, a form of skin cancer, originates in melanocytes—the cells that produce skin pigment. This increase in melanoma cases is attributed to factors like extended sun exposure, the use of tanning beds, and genetic susceptibility. Imlygic (talimogene laherparepvec) functions as an oncolytic viral therapy, administered directly into melanoma tumors to facilitate localized tumor destruction and stimulate a systemic anti-tumor immune response. For example, data from the US-based biomedical library, the National Library of Medicine, indicated in December 2023 that melanoma cases in the EU-27 (27 member countries of the European Union (EU) ) totaled 101,510 in 2022, with projections showing a rise to 115,540 by 2040. Consequently, the growing incidence of melanoma is acting as a primary driver for the Imlygic market’s expansion.

Which Segment Classifications Shape The Imlygic Market?

The imlygic market covered in this report is segmented –

1) By Patient Demographics: Pediatric Patients, Adult Patients

2) By Distribution Channel: Hospitals, Specialty Clinics, Online Pharmacies, Retail Pharmacies

3) By Application: Melanoma Treatment, Combination Therapy, Other Cancer Types

Which Companies Are Expanding Their Footprint In The Imlygic Market?

Major companies operating in the imlygic market are Amgen Inc.

Read the full imlygic market report here:

https://www.thebusinessresearchcompany.com/report/imlygic-global-market-report

How Does The Imlygic Market Perform Across Major Global Regions?

North America was the largest region in the imlygic market in 2025. The regions covered in the imlygic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Imlygic Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20097&type=smp

Browse Through More Reports Similar to the Global Imlygic Market 2026, By The Business Research Company

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Investments Market Report 2026

https://www.thebusinessresearchcompany.com/report/investments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795